A. Faust et al., EFFECT OF LIPOIC ACID ON CYCLOPHOSPHAMIDE-INDUCED DIABETES AND INSULITIS IN NONOBESE DIABETIC MICE, International journal of immunopharmacology, 16(1), 1994, pp. 61-66
In an animal model of type I diabetes, the non-obese diabetic (NOD) mo
use, the influence of the antioxidant lipoic acid (LA) on the developm
ent of diabetes was investigated. Acceleration of diabetes development
with cyclophosphamide (CY) resulted in 60% diabetic animals with seve
rely infiltrated islets within 1 - 3 weeks. Daily administration of li
poic acid for 20 or 30 days around cyclophosphamide treatment suppress
ed the incidence of diabetes to 30% (P<0.05) and 33%, respectively. Se
miquantitative analysis of islet infiltration showed a reduction of se
vere intraislet infiltration and an increase in the percentage of isle
ts with mild peri-insular and periductular infiltrates (from 8.4 to 29
.6 and 25.9%, respectively, P<0.01) after lipoic acid treatment. These
results show that the protective effect of lipoic acid on diabetes de
velopment correlates with partial suppression of islet inflammation. T
he anti-inflammatory action of lipoic acid may be due to its ability t
o scavenge oxygen radicals and to suppress nitric oxide production.